Background A growing body of evidence suggests that atrial fibrillation (AF) is associated
with myocardial infarction (MI). However, incidence and management of MI in AF is still …

Significance: The incidence of cardiovascular events (CVEs) increases with age,
representing the main cause of death in an elderly population. Aging is associated with …

Background & Aims Patients with non-alcoholic fatty liver disease (NAFLD) are at increased
chance for cardiovascular events (CVEs). Severity of liver fibrosis is used to determine …

Background The incidence of atrial fibrillation (AF) is increasing, conferring a major health-
care issue in Asia. No risk score for predicting incident AF has been specifically developed …

Objective To investigate the impact on cardiovascular events (CVEs) in a real-world
population of patients with atrial fibrillation (AF) by implementing the Atrial fibrillation Better …

Abstract BACKGROUND The Atrial fibrillation Better Care (ABC) pathway has been
proposed to streamline patient management in an integrated, holistic manner. Compliance …

Objectives To investigate the incidence of bleeding events in atrial fibrillation (AF) patients
treated with vitamin K (VKAs) or non-vitamin K antagonist oral anticoagulants (NOACs) …

Statins are effective for reducing cardiovascular disease in patients at risk or with
cardiovascular disease. The benefit of statin therapy on adverse cardiovascular outcomes in …

Background Experimental studies demonstrated that glutathione peroxidase 3 (GP x3), an
antioxidant enzyme that catabolizes hydrogen peroxide, protects against thrombosis. Little is …

Recent findings suggest that patients with non-valvular atrial fibrillation (AF), in addition to
having a high risk for ischemic stroke, are also at risk for myocardial infarction (MI). The aim …